Chin, Circuit Judge:
In this case, intervenor-defendant-appellee Sarepta Therapeutics, Inc. ("Sarepta") obtained accelerated approval from defendant-appellee the Food and Drug Administration (the "FDA") for a drug Sarepta created to treat a neuromuscular disease. During the approval process, which spanned some nine years, Sarepta submitted tens...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.